Survival analysis ii: Cox regression

Nephron - Clinical Practice

Volumn 119, Issue 3, 2011, Pages

  Stel, Vianda S ^a   Dekker, Friedo W ^a,b   Tripepi, Giovanni ^c   Zoccali, Carmine ^c   Jager, Kitty J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Cox regression; Epidemiology; Nephrology; Survival analyses

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; DIALYSIS; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURVIVAL;

CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; PROPORTIONAL HAZARDS MODELS;

EID: 80255123908     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000328916     Document Type: Article

References (10)

1. Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ: Survival analyses 1: the Kaplan-Meier method. Nephron Clin Pract 2011; 119:c83-c88.
2. Stel VS, Dekker FW, Ansell D, et al: Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant 2009; 24: 3175-3182.
3. Noordzij M, Dekker FW, Zoccali C, Jager KJ: Measures of disease frequency: prevalence and incidence. Nephron Clin Pract 2010; 115:c17-c20.
4. Jager KJ, Zoccali C, Kramar R, Dekker FW: Measuring disease occurrence. Kidney Int 2007; 72: 412-415. (Pubitemid 47237611)
5. van Dijk PC, Jager KJ, Zwinderman AH, et al: The analysis of survival data in nephrology: basic concepts and methods of Cox regression. Kidney Int 2008; 74: 705-709.
6. van Stralen KJ, Dekker FW, Zoccali C, Jager KJ: Confounding. Nephron Clin Pract 2010; 116:c143-c147.
7. Jager KJ, Zoccali C, Macleod A, Dekker FW: Confounding: what it is and how to deal with it. Kidney Int 2008; 73: 256-260.
8. Tripepi G, Jager KJ, Dekker FW, et al: Measures of effect: relative risks, odds ratios, risk difference, and 'number needed to treat'. Kidney Int 2007; 72: 789-791. (Pubitemid 47469592)
9. von EE, Altman DG, Egger M, et al: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
10. Schulz KF, Altman DG, Moher D: CONSORT 2010. statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340:c332.